CarysBio is a contract R&D organization, focusing on the support of pharmaceutical and biotechnology companies. CarysBio’s forté is human hepatocyte sandwich cultures that mimic the 3D structure in vivo, forming the bile canaliculi for drug excretion. We specialize in drug transporters. Our customized assay development services include a full range of primary culture systems and in vivo surgical models adapted to clients specific needs.